Discover
NXTC
NextCure, Inc.
7.18
2 x 3.64
2 x 6.33
bid
ask
+
0.40
5.90%
2 @ 04:00 PM
7.18 +0.00 (0.00%)
| Ytd | -49.40% | |
| 1y | 9.95% |
6.30
day range
7.20
1.60
52 week range
14.27
| Open | 6.67 | Prev Close | 6.78 | Low | 6.30 | High | 7.20 | Mkt Cap | 32.87M |
| Vol | 85.75K | Avg Vol | 2.11M | EPS | -8.71 | P/E | N/A | Forward P/E | -0.66 |
| Beta | 0.79 | Short Ratio | 1.89 | Inst. Own | 57.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 6.25 | 200-d Avg | 8.40 | 1yr Est | 3.33 |
| Income Statement | |||
| Operating Expenses | 15.09M | ||
| Research and Development Expense | 7.43M | ||
| Selling, General and Administrative Expense | 2.59M | ||
| Operating Income | -15.09M | ||
| Net Income | -14.89M | ||
| Net Income Common Stock | -14.89M | ||
| Net Income Common Stock (USD) | -14.89M | ||
| Consolidated Income | -14.89M | ||
| Earnings per Basic Share | -2.80 | ||
| Earnings per Basic Share (USD) | -2.80 | ||
| Earnings per Diluted Share | -2.80 | ||
| Earning Before Interest & Taxes (EBIT) | -14.89M | ||
| Earning Before Interest & Taxes (USD) | -14.89M | ||
| Weighted Average Shares | 5.31M | ||
| Weighted Average Shares Diluted | 5.31M | ||
| Balance Sheet | |||
| Cash and Equivalents | 15.26M | ||
| Cash and Equivalents (USD) | 15.26M | ||
| Investments | 4.83M | ||
| Investments Current | 4.83M | ||
| Current Assets | 22.26M | ||
| Property, Plant & Equipment Net | 283.00K | ||
| Total Assets | 22.62M | ||
| Total Debt | 3.60M | ||
| Current Liabilities | 6.41M | ||
| Debt Non-Current | 3.60M | ||
| Total Liabilities | 10.47M | ||
| Accumulated Retained Earnings (Deficit) | -460.67M | ||
| Accumulated Other Comprehensive Income | -3.00K | ||
| Shareholders Equity | 12.15M | ||
| Shareholders Equity (USD) | 12.15M | ||
| Assets Non-Current | 365.00K | ||
| Total Debt (USD) | 3.60M | ||
| Liabilities Non-Current | 4.06M | ||
| Trade and Non-Trade Payables | 2.58M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 433.00K | ||
| Net Cash Flow from Financing | 22.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 93.00K | ||
| Issuance (Purchase) of Equity Shares | 22.00K | ||
| Net Cash Flow from Investing | 9.79M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 9.79M | ||
| Net Cash Flow from Operations | -9.71M | ||
| Share Based Compensation | 304.00K | ||